Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iveric Bio Inc (NQ: ISEE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Iveric Bio Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 December 29, 2023 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023. Via Benzinga From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs July 07, 2023 Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... Via Benzinga IVERIC bio Inc. (NASDAQ: ISEE) Records 52-Week High Thursday Morning July 06, 2023 Via Investor Brand Network IVERIC bio Inc. (NASDAQ: ISEE) Making Surprising Moves in Monday Session June 05, 2023 Via Investor Brand Network The Latest Analyst Ratings for IVERIC bio April 25, 2023 Via Benzinga Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 05, 2023 From IVERIC bio, Inc. Via Business Wire IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE June 14, 2023 From Kahn Swick & Foti, LLC Via Business Wire Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 02, 2023 From IVERIC bio, Inc. Via Business Wire The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree June 02, 2023 Big Pharma is facing a patent cliff that could siphon off billions in revenue. Via Investor's Business Daily Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition? June 01, 2023 By David Willey, Benzinga Via TheNewswire.com Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition? June 01, 2023 Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition? Via News Direct Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition? May 30, 2023 The Japanese healthcare company Astellas Pharma, Inc. (OTC: ALPMF) recently announced its acquisition of the biopharmaceutical company Iveric Bio Via Benzinga Why Shares of Annexon Are Plummeting Thursday May 25, 2023 Mixed trial results on a geographic atrophy eye drug led investors to sell the biotech stock. Via The Motley Fool Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 24, 2023 From IVERIC bio, Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session May 08, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023 May 04, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023 May 03, 2023 Via Benzinga IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE May 02, 2023 From Kahn Swick & Foti, LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023 May 02, 2023 Via Benzinga Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today May 01, 2023 These three biotech stocks were on the volatile side today. Via The Motley Fool BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iveric Bio Inc. (Nasdaq – ISEE), Midwest Holding Inc. (Nasdaq – MDWT), Hoth Therapeutics, Inc. (Nasdaq – HOTH) May 01, 2023 From Brodsky & Smith LLC Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023 May 01, 2023 Via Benzinga Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma May 01, 2023 The company is working on a treatment for the eye disease known as geographic atrophy. Via Investor's Business Daily First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories May 01, 2023 Benzinga Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 01, 2023 Via Benzinga Nasdaq, S&P 500 Futures On Edge Over First Republic Failure, Tech Earnings: Analyst Pins Hopes On Fed's Next Move May 01, 2023 Stocks have reverted to their cautious ways on Monday amid a slew of market-moving catalysts. Via Benzinga Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration' May 01, 2023 Japanese healthcare company Astellas Pharma Inc (OTC: ALPMY) has agreed to buy Iveric Bio Inc (NASDAQ: ISEE) for $40.00 per share in cash for a total equity value of Via Benzinga IVERIC bio, Ascendis Pharma And Other Big Stocks Moving Higher In Monday's Pre-Market Session May 01, 2023 U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Apollomics, Inc. (NASDAQ: APLM) surged 58.4% to $7.35 in pre-market trading... Via Benzinga ISEE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Iveric bio, Inc. Is Fair to Shareholders May 01, 2023 From Halper Sadeh LLC Via Business Wire Astellas Enters Into Definitive Agreement to Acquire Iveric Bio April 30, 2023 From IVERIC Bio, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
